Systemic Sclerosis, Diffuse
3 clinical trials · Condition
◉ Watch Systemic Sclerosis, Diffuse
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients (NCT04837131) | Michael M. Pham | 2021-04-28 |
| Iguratimod in Systemic Sclerosis (NCT04515706) | RenJi Hospital | 2021-01-01 |
Track Systemic Sclerosis, Diffuse automatically
Every clearance here is in the API, with alerts when new ones post.